WHO ICTRP trial
Subthreshold micropulse yellow (577nm) laser versus half-dose photodynamic…
ACTRN12617000096358 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12617000096358 |
|---|---|
| Public title | Subthreshold micropulse yellow (577nm) laser versus half-dose photodynamic therapy for central serous chorioretinopathy : a randomized controlled pilot study |
| Scientific title | Subthreshold micropulse yellow (577nm) laser versus half-dose photodynamic therapy for central serous chorioretinopathy : a randomized controlled pilot study |
| Primary sponsor | Brelen Marten Erik |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Conditions | Central serous chorioretinopathy |
| Interventions | Half-dose Photodynamic therapy The Photodynamic therapy (PDT)(intravenous infusion) will be performed using half-dose verteporfin (Visudyne; Novartis). For this, 3 mg/m2 of verteporfin will be infused over 10 minutes, and 15 minutes after… |
| Registration date | Jan 17, 2017 |
| Target size | 120 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: